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Abstract. This article discusses a study performed with an aim to determine the usefulness of 
diffusion-weighted MRI in pre-treatment assessment and evaluation of chemotherapy response of 
mediastinal lesions of malignant lymphoma by analysing signal intensity, accumulation of 
contrast agent and changes in values of ADC. Comparing the results of PET/CT and DW-MRI 
was another goal of this study. We reviewed data of 21 patients that underwent treatment during 
years 2013-2014 at the Hospital of Lithuanian University of Health Sciences Kaunas Clinics and 
had DW-MRI and PET/CT scans carried out. For all patients the diagnosis of malignant lymphoma 
in mediastinal lymph nodes was confirmed histological. Whether the lymphoma was in active 
state was determined by PET/CT or histological data. In MRI scans, signal intensity and ADC 
values were evaluated, while in PET/CT maximum and average standardized uptake values were 
assessed. Patients underwent chemotherapy and follow up scans were performed to evaluate 
response. In total, 25 PET/CT and 50 DW-MRI scans were analysed. We found statistically 
significant difference of values of ADC in active and inactive states of malignant lymphoma of 
mediastinal lymph nodes. In follow up tests, performed during 2 years after treatment, a tendency 
of decreasing ADC values over time was seen when chemotherapy was successful and no relapse 
was observed. Among the reviewed cases, DW-MRI had slightly worse specificity than PET/CT 
in differentiation of malignant and benign changes in lymph nodes. 
Keywords: malignant lymphoma, diffusion-weighted magnetic resonance imaging (DW-MRI), 
apparent diffusion coefficient (ADC), positron emission tomography/computed tomography 
(PET/CT). 
1. Introduction 
Lymphomas are a group of lymph proliferative diseases, classified into two types – Hodgkin’s 
and non-Hodgkin’s lymphomas. Morbidity for this illness seems to be rising lately, as about 450 
new cases of lymphoma are found in Lithuania yearly [1]. Hodgkin’s lymphomas are usually 
diagnosed for people at the age of 20-30 years, meaning it’s a disease of young, active and working 
age people. Fortunately, malignant lymphomas show great response to chemotherapy, although 
the treatment has harsh side effects and oftentimes can be hard for patients to tolerate. Finding an 
optimal treatment strategy is one of the main goals when assessing lymphomas. Employing 
radiologic methods for correct primary staging of tumour and evaluation of response to treatment 
allows optimising the use of chemotherapy. Early assessment of the effect of chemotherapy means 
that treatment tactics can be changed or corrected on an early stage of disease, if seen not to be 
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effective enough, while minimizing toxicity and expenses of ineffective chemotherapy and 
maximising the probability of successful outcomes [2]. 
For a long time computed tomography (CT) scans were used as the main method for 
assessment of lymphomas. Lately positron emission tomography combined with computed 
tomography (PET/CT) was tried to use more and more often and now became the standard for 
imaging lymphomas. The main drawback of PET could be lack of detailed anatomical information, 
while CT alone doesn’t account for the clear functional changes in tissues. Fusing these images 
eliminates these drawbacks, allowing combining anatomical information of CT with functional 
information of PET in addition to better signal attenuation [3], thus improving both sensitivity and 
specificity of the scans. However, PET/CT is a costly, relatively slow sophisticated imaging 
technique and, most importantly, exposes the patient to marked ionizing radiation, so, as new 
imaging sequences are developed, diffusion-weighted magnetic resonance imaging (DW-MRI) 
could becoming a viable alternative to PET/CT. Its usefulness is apparent when scanning children, 
pregnant women or multiple follow-up tests have to be performed after treatment, as minimizing 
the amount of ionizing radiation gains even greater importance [2]. Also DW-MRI can be 
successfully used for patients allergic to iodine based contrast agent which is a common problem 
performing CT. 
For the last few years, the use of MRI and DW-MRI for imaging tumours of lungs and 
mediastinum is becoming more frequent in Lithuania. MRI, combined with diffusion-weighted 
imaging can be used to assess both the morphology and functional activity of mediastinal tissue. 
One of significant advantages of DW-MRI could be high lesion to background tissue contrast, 
which allows better accuracy in determining the margins of lesion [4]. Higher soft-tissue contrast 
and higher spatial resolution compared to PET/CT makes false positive and false negative results 
less likely [5]. Prime cause of it is that MRI diffusion is based on the difference of movement of 
water molecules in biological tissues. Malignant tissues tend to have hyper cellular structure with 
enlarged hyper chromatic nuclei and high levels of macromolecular proteins. All these factors lead 
to a reduction of diffusion space for water molecules, resulting in the decrease of apparent 
diffusion coefficient (ADC) values. However, in necrotic tissue, breakdown of diffusion barriers 
facilitates the movement of water molecules, thus increasing the value of ADC [2]. Chemotherapy 
treatment also alters the structure of tumour tissue, leading to changes of ADC, what suggests 
DW-MRI is valuable in evaluation of treatment response or tumour relapse. Based on modern 
literature findings, DW-MRI could be a valid alternative to PET/CT in oncology, although further 
analysis is needed for specific tumour types such as lymphomas [5]. 
This study aimed to compare the diagnostic value of DW-MRI and PET/CT and specify 
whether it can be used as an alternative in diagnostics of mediastinal lesions of lymphomas. 
2. Materials and methods 
This retrospective study was performed at the Lithuanian University of Health Sciences 
Clinical Hospital, Department of Radiology. Clinical data and radiologic findings of 21 patients 
were reviewed. All of the patients had previously diagnosed lymphoma of mediastinal lymph 
nodes and underwent treatment during period of 2013-2014 years.  DW-MRI and PET/CT scans 
were carried out for every patient. Diagnosis of malignant lymphoma was confirmed in 
accordance to histological findings for all patients. The patient group consisted of 12 women and 
9 men, age varied from 21 to 78 years (39±15.6 years average) whether the lymphoma was in an 
active state and was determined by PET/CT or histological data. MRI scans were performed with 
paramagnetic contrast agent using 1.5T Siemens Magnetom Avanto scanner, T1, T2, DWI 
sequences were carried out, using b values of 50, 400 and 800 s/mm2for diffusion images [18]. 
F-FDG radiopharmaceutical was used for PET/CT scans. In MRI scans, signal intensity and ADC 
values were evaluated, while maximum and average standardized uptake values were assessed in 
PET/CT scans. Patient underwent from 4 to 8 courses of chemotherapy, follow-up DW-MRI and 
PET/CT scans were performed to evaluate response when all courses were finished. 25 PET/CT 
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and 50 DW-MRI scans were analysed. 20 patients had PET/CT and DW-MRI performed at the 
same stage of disease, the findings of which were compared considering histological data when 
findings were different between the two modalities. Lymphoma tissue was considered inactive if 
the masses disappeared or transformed into fibrous tissue. 
Data was analysed using IBM SPSS statistics packet22.0. We used independent samples ܶ test 
and Spearman correlation coefficient, data was considered statistically significant, when ݌ ≤ 0.05. 
3. Results 
Each of 21 patients had histological confirmed malignant lymphoma. Hodgkin’s lymphoma 
was diagnosed for 18 (85.7 %) patients, while non-Hodgkin’s lymphoma– for 3 (14.3 %) of 
patients. The average age of patients with Hodgkin’s lymphoma was lower, averaging 35 (SD – 
9.64) years, while non-Hodgkin’s lymphoma’s average was 65 (SD – 21.65) years. 14.3 %  
(݊ = 3) of lymphomas were of stage I, 42.9 % (݊ = 9) – stage II, 23.8 % (݊ = 5) – stage III, 19 %  
(݊ = 4) – stage IV. The locations of lesions (sometimes a few locations on the same patient) were 
founded as follows: sternal notch nodes – 90.5 % (݊  = 19), paratracheal –76.2 % (݊  = 16), 
para-aortic – 47.6 % (݊  =1 0), hilar – 33.3 % (݊  = 7), bifurcational – 23.8 % (݊  = 5) and 
paracardial 9.5 % (n=2) of cases. 
The average ADC value of active lymphoma was 1.131×10-3 (SD = 0.41×10-3) mm2/s, while 
the average ADC value of inactive lymphoma was 0.391×10-3 (SD = 0.552×10-3) mm2/s. The 
difference in ADC was statistically significant (݌ < 0.01). Calcification of lymph nodes made 
measuring average values of ADC difficult, causing high dispersion. In cases when successful 
outcome of treatment was known (lymphoma masses were inactive and no relapse was observed), 
follow-up scans performed in 2 years after treatment were analysed. Inverse correlation between 
time after treatment and value of ADC was seen (ߩ = –0.527, ݌ = 0.027) – values of ADC 
decreased as more time passed between follow up tests and final course of chemotherapy. 
The results of DW-MRI and PET/CT carried out at the same stage of disease matched in 20 
cases (95.24 %), where tumour characteristics such as maximum and average standardised uptake 
value (SUVmax, SUVavg) in PET/CT and ADC values in DW-MRI both suggested active or 
inactive state of lymphoma (Figs. 1, 2, 3), however in one case (4.76 %), DW-MRI could not 
reliably determine whether the tissue was malignant or not due to inflammatory reaction. A 
PET/CT scan had to be performed, which proved to be more specific, showing inactive state of 
lymphoma. 
4. Discussion 
In our cohort, diffusion-weighted MRI proved to be a reliable method for determining between 
active and inactive states of lymphoma, allowing evaluating both morphological and functional 
parameters of tumour. However, in a small amount of cases, MRI lacked enough specificity to 
differentiate between malignant tissue and changes in functional activity due to inflammation, and 
was requiring a simultaneous PET/CT scan. Every so often the post-treatment inflammatory 
process and particularly macrophage proliferation may cause false-positive findings on both 
diffusion MRI and PET/CT [6]. Both methods show significant changes of parameters between 
active and inactive state of lymphomas, so, owing to its safety compared to PET/CT with its 
subsequent marked ionizing radiation, DW-MRI can be a valuable alternative for initial 
assessment of lymphoma and its advantages are enhanced especially when multiple follow-up 
scans are necessary. 
The ADC maps are usually calculated using three b values, with the first being close to 0 and 
the third being a multiple of second value. In our case we used b values of 50, 400 and 800 s/mm2. 
The b value is a factor that determines how much effect fast or slow diffusion in tissues has on 
signal intensity. The relation between signal intensity and b value is reflected by the 
Stejskal-Tanner formula (Eq. 1): 
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ܵ = ܵ௢݁ି௕஽, (1)
where ܵ is the signal intensity after applying diffusion gradients, ܵ௢ is the baseline signal intensity, 
ܦ is the apparent diffusion coefficient. 
In conventional sequences, the effect of diffusion is miniscule. However, when multiple 
diffusion gradients are applied in DW imaging, these effects are amplified and become the main 
mechanism of tissue contrast [7]. Diffusion weighted images still contain contributions from spin 
densities and T1 and T2 relaxation times. Therefore, single diffusion weighted images can have a 
“T2 shine through” effect when a hyper intense lesion reflects strong T2 effect instead of reduced 
diffusion. By using more than one diffusion weighted image using different diffuse sensitization 
(b values), the effect of these factors can be eliminated and diffusion coefficient maps produced. 
ADC maps can be acquired with as few as two b values by calculating the apparent diffusion 
coefficient for each pixel: 
ADC = ܫ݊ሾܵଶ/ ଵܵሿ/ሺܾଵ − ܾଶሻ, (2)
where ADC – a measure of magnitude of diffusion, ଵܵ is the signal intensity when ܾ = ܾଵ, ଵܵ ≠
0; ܵଶ is the signal intensity when ܾ = ܾଶ; ܾଵ is the baseline ܾ value, usually close to 0, ܾଵ ≠ ܾଶ; 
ܾଶ is the second b value, ܾଶ ≠ ܾଵ. 
When using more ܾ values, the best fitting line for exponential decrease of signal intensity is 
calculated. However, it does not affect the line slope, which represents ADC and there in no 
change in its value [8]. After calculating ADC for each pixel, this data is visually presented as an 
ADC map. The coefficient is called apparent, because D value, or, in this case the ADC depends 
on experimental conditions. Average ADC values for a selected area in ADC map can be acquired. 
Chemotherapy causes apoptosis of tumour cells, which shrink, leading to an increase in 
extracellular space, consequently increasing the value of ADC [9]. Later, as the tumour tissue 
reorganises and transforms into fibroid tissue, the ADC value drops. When analysing follow-up 
scans, in one case when tumour relapse was observed, the ADC value stayed elevated after 2 and 
4 months post-treatment, so in this case the ADC value could be successfully used to predict 
relapse. 
The use of DW-MRI in diagnosis of lymphoma picked up speed only several years ago and 
research concerning this matter is limited, however studies performed by other authors also 
showed comparable results. For illustration, Siegel et al. compared ADC values before treatment 
and after 2 courses of chemotherapy. Percentage changes in values for ADC were tested for 
differences from zero with the Wilcoxon signed-rank test. The medians and 25-75th percentile 
ranges were used for descriptive statistics. They proved that before treatment, average ADC value 
was 0,772×10-3 mm2/s, whereas after 2 courses of chemotherapy, the average statistically 
significantly increased by 85 % to 1,561×10-3 mm2/s. Findings of DW-MRI and PET/CT were 
also compared. The results matched in 97 % of cases, while Ann-Arbor stage matched in all cases. 
After 2 courses of chemotherapy 5 of 49 tumour sites remained abnormal on both DW-MRI and 
PET/CT, and there was one false positive on DW-MRI [10]. As in our case, a significant change 
of ADC was seen during treatment, while DW-MRI provided comparable results to those of 
PET/CT. 
K. Tsuji et al. assessed the concordance of tumour stage between DW-MRI and PET/CT. 
Using MRI T2 sequences combined with diffusion imaging, the findings were same in 92, 86 % 
of cases. They also founded a significant difference in progress-free survival between patients 
with lesion positive and lesion negative MRI findings [11]. DW-MRI showed to be a valid 
alternative to PET/CT for differentiation of active and inactive lymphoma.  
At the University of Pennsylvania Ming Q. Huang et al. performed a study aiming to evaluate 
the possible use of DW-MRI to detect response of human diffuse large ߚ -cell lymphoma 
xenografts in severe combined immune deficient mice to chemotherapy. A significant change in 
both ADC value and T2 relaxation time were observed after one week of CHOPB chemotherapy 
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[9]. These results suggest that DW-MRI can be used to evaluate the effectiveness of treatment at 
an early stage, allowing changing treatment strategy as soon as possible, avoiding the harmful side 
effects of/or ineffective treatment. 
In our study, the change of ADC during the course of treatment could not be analysed due to 
lack of MRI scans performed mid-treatment, thus a prospective study would be valuable in 
determining the value of diffusion-weighted MRI for early assessment of treatment response in 
the future studies. However, a strong point of this study is the homogeneity of the cohort as lesion 
location and standard chemotherapy are the same for all patients and do not distort the results. 
Also the availability of follow up data, although currently limited to a couple of years, allowed to 
evaluate the dynamics of radiologic findings post-treatment. 
 
Fig. 1. A 26-year-old female patient with histological confirmed Hodgkin’s lymphoma. PET/CT scan using 
[18] F-FDG radiopharmaceutical before (A) and after (B) treatment. Arrows show lymphoma masses with 
high FDG metabolism. No zones of high contrast accumulation were seen after treatment. 
 
Fig. 2. Diffusion-weighted MRIT1WIBE (A) and ADC map (B) of the same patient. White arrows show 
active tumour masses of high signal intensity with an average ADC value of 1.42×10-3 mm2s. 
 
Fig. 3. DW-MRIT1WIBE (A) and ADC map (B) of the same patient after chemotherapy course. No 
masses of high signal intensity are observed in DW images with b values of 50, 400 and 800 s/mm2.  
In ADC map, the ADC value is lowering (immeasurable) in the former site of lymphoma masses. 
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Algidas Basevicius – head of Radiology Department, LUHS Clinical Hospital; research 
coordinator. Laima Dobrovolskiene – collection and analysis of DW-MRI scans. Rytis Bliudzius 
– collection and analysis of PET/CT scans. Matas Juskevicius – selection of patients with 
lymphomas. Vincentas Veikutis – research coordination, statistical analysis. Vaidas Oberauskas 
– technical assistance, histology findings analysis. 
5. Conclusions 
We founded a statistically significant difference of values of ADC in active and inactive states 
of malignant lymphoma of mediastinal lymph nodes. Also statistically significant decrease of 
ADC value was observed after successful chemotherapy. Among the reviewed cases, DW-MRI 
had slightly worse specificity than PET/CT in differentiation of malignant and benign changes in 
lymph nodes, however further research of DW-MRI in diagnosis of malignant lymphomas should 
be carried out reviewing more cases to better compare the usefulness of these modalities. 
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